| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |